name:-0.89482498168945
name:-0.95676112174988
name:-0.14691996574402
Vertex Pharmaceuticals Incorporated Patent Filings

Vertex Pharmaceuticals Incorporated

Patent Applications and Registrations

Patent applications and USPTO patent grants for Vertex Pharmaceuticals Incorporated.The latest application filed is for "modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator".

Company Profile
200.200.200
  • Vertex Pharmaceuticals Incorporated - Boston MA US
  • Vertex Pharmaceuticals Incorporated -
  • VERTEX PHARMACEUTICALS INCORPORATED - Cambridge MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks
Patent Activity
PatentDate
Modulator Of Cystic Fibrosis Transmembrane Conductance Regulator, Pharmaceutical Compositions, Methods Of Treatment, And Process For Making The Modulator
App 20220306606 - Alcacio; Timothy ;   et al.
2022-09-29
Modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
Grant 11,453,655 - Abela , et al. September 27, 2
2022-09-27
Antiproliferation compounds and uses thereof
Grant 11,440,907 - Yu , et al. September 13, 2
2022-09-13
Processes for preparing pyrrolidine compounds
Grant 11,434,201 - Angell , et al. September 6, 2
2022-09-06
Modulators of cystic fibrosis transmembrane conductance regulator
Grant 11,426,407 - Miller , et al. August 30, 2
2022-08-30
Materials and methods for treatment of myotonic dystrophy type 1 (DM1) and other related disorders
Grant 11,427,838 - Lundberg , et al. August 30, 2
2022-08-30
Pharmaceutical Compositions For Treating Cystic Fibrosis
App 20220257564 - Chu; Cathy ;   et al.
2022-08-18
Materials And Methods For Treatment Of Hemoglobinopathies
App 20220259578 - Chakraborty; Tirtha ;   et al.
2022-08-18
Modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
Grant 11,414,439 - Abela , et al. August 16, 2
2022-08-16
Method For Treating Cancer Using A Combination Of Chk1 And Atr Inhibitors
App 20220249489 - HELLEDAY; Thomas ;   et al.
2022-08-11
Pharmaceutical Composition And Administrations Thereof
App 20220241206 - DOKOU; Eleni ;   et al.
2022-08-04
Enhanced Differentiation Of Beta Cells
App 20220233646 - CAREY; Bryce
2022-07-28
Pancreatic Differentiation
App 20220235327 - HARB; George ;   et al.
2022-07-28
Compounds Useful As Inhibitors Of Atr Kinase And Combination Therapies Thereof
App 20220233521 - POLLARD; John Robert ;   et al.
2022-07-28
Compositions And Methods For Editing Beta-globin For Treatment Of Hemaglobinopathies
App 20220228142 - D'SOUZA; Sanjay ;   et al.
2022-07-21
Crystalline forms of C.sub.21H.sub.22Cl.sub.2N.sub.4O.sub.2
Grant 11,390,600 - DeCrescenzo , et al. July 19, 2
2022-07-19
Materials And Methods For Treatment Of Hemoglobinopathies
App 20220211874 - Cowan; Chad Albert ;   et al.
2022-07-07
Compounds useful as inhibitors of ATR kinase
Grant 11,370,798 - Ahmad , et al. June 28, 2
2022-06-28
Materials and methods for treatment of Duchenne Muscular Dystrophy
Grant 11,369,692 - Kabadi , et al. June 28, 2
2022-06-28
Compositions and Methods for Treatment of Disorders Associated with Repetitive DNA
App 20220186216 - Dokshin; Gregoriy Aleksandrovich ;   et al.
2022-06-16
Methods Of Treatment For Cystic Fibrosis
App 20220184049 - Borek; Bartlomiej ;   et al.
2022-06-16
Deuterated pyridone amides and prodrugs thereof as modulators of sodium channels
Grant 11,358,977 - Jiang , et al. June 14, 2
2022-06-14
Macroencapsulation Devices
App 20220175511 - Thanos; Christopher ;   et al.
2022-06-09
Methods of preparing inhibitors of influenza viruses replication
Grant 11,345,700 - Tanoury , et al. May 31, 2
2022-05-31
Modulators Of Atp-binding Cassette Transporters
App 20220153729 - HADIDA RUAH; Sara S. ;   et al.
2022-05-19
Multicompartment Macroencapsulation Devices
App 20220143374 - Thanos; Christopher ;   et al.
2022-05-12
Mannose Derivatives for Treating Bacterial Infections
App 20220135609 - Ramtohul; Yeeman K. ;   et al.
2022-05-05
Esters And Carbamates As Modulators Of Sodium Channels
App 20220110923 - Thomson; Stephen Andrew
2022-04-14
Modulators of Cystic Fibrosis Transmembrane Conductance Regulator, Pharmaceutical Compositions, Methods of Treatment, and Process for Making the Modulators
App 20220106331 - Clemens; Jeremy J. ;   et al.
2022-04-07
Inhibitors Of Apol1 And Methods Of Using Same
App 20220106327 - AHN; Jun Myun ;   et al.
2022-04-07
Methods, Compositions And Kits For Increasing Genome Editing Efficiency
App 20220106615 - Abdul-Manan; Norzehan ;   et al.
2022-04-07
Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline- -3-carboxamide
Grant 11,291,662 - Hurter , et al. April 5, 2
2022-04-05
Compositions and Methods for Treatment of Duchenne Muscular Dystrophy
App 20220096606 - Gromada; Jesper ;   et al.
2022-03-31
Differentiation Of Pancreatic Endocrine Cells
App 20220090020 - Harb; George ;   et al.
2022-03-24
Method For Treating Cancer Using A Combination Of Dna-damaging Agents And Dna-pk Inhibitors
App 20220088043 - Boucher; Diane ;   et al.
2022-03-24
Materials and methods for treatment of hemoglobinopathies
Grant 11,268,077 - Chakraborty , et al. March 8, 2
2022-03-08
Methods of treatment for cystic fibrosis
Grant 11,253,509 - Chen , et al. February 22, 2
2022-02-22
Methods Of Treatment For Cystic Fibrosis
App 20220047564 - ALTSHULER; David M. ;   et al.
2022-02-17
Modulators Of Cystic Fibrosis Transmembrane Conductance Regulator
App 20220041621 - Clemens; Jeremy J. ;   et al.
2022-02-10
Pharmaceutical Compositions Of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) Cyclopropanecarboxamido)-3-methylpyridin-2-yl) Benzoic Acid And Administration Thereof
App 20220031679 - VERWIJS; Marinus Jacobus ;   et al.
2022-02-03
Stem Cell Derived Islet Differentiation
App 20210403875 - Pagliuca; Felicia J. ;   et al.
2021-12-30
Gene-editing Systems For Editing A Cystic Fibrosis Transmembrane Regulator (cftr) Gene
App 20210403906 - Weinberg; Marco ;   et al.
2021-12-30
Stem Cell Derived Islet Differentiation
App 20210403876 - Pagliuca; Felicia J. ;   et al.
2021-12-30
Sulfonamides as modulators of sodium channels
Grant 11,203,571 - Hadida-Ruah , et al. December 21, 2
2021-12-21
Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
Grant 11,186,566 - Alcacio , et al. November 30, 2
2021-11-30
CRISPR/CAS Systems For Treatment of DMD
App 20210363521 - Police; Seshidhar Reddy ;   et al.
2021-11-25
Pharmaceutical compositions for treating cystic fibrosis
Grant 11,179,367 - Chu , et al. November 23, 2
2021-11-23
Method for treating cancer using a combination of Chk1 and ATR inhibitors
Grant 11,179,394 - Helleday , et al. November 23, 2
2021-11-23
Solid Forms of (R)-1(2,2-Difluorobenzo[D][1,3]Dioxol-5-yl)-N-(1-(2,3-Dihydroxypropyl)-6-- Fluoro-2-(1-Hydroxy-2-Methylpropan-2-yl)-1H-Indol-5-yl)Cyclopropanecarboxa- mide
App 20210340128 - Keshavarz-Shokri; Ali ;   et al.
2021-11-04
Crystalline forms and compositions of CFTR modulators
Grant 11,155,533 - Dhamankar , et al. October 26, 2
2021-10-26
Pharmaceutical composition and administrations thereof
Grant 11,147,770 - Dokou , et al. October 19, 2
2021-10-19
Materials And Methods For Treatment Of Hemoglobinopathies
App 20210317450 - Porteus; Matthew Hebden
2021-10-14
Pharmaceutical Compositions For The Treatment Of Cystic Fibrosis Transmembrane Conductance Regulator Mediated Diseases
App 20210308053 - Phenix; Brian Dean ;   et al.
2021-10-07
Methods, compositions and kits for increasing genome editing efficiency
Grant 11,124,805 - Abdul-Manan , et al. September 21, 2
2021-09-21
Compounds useful as inhibitors of ATR kinase
Grant 11,117,900 - Ahmad , et al. September 14, 2
2021-09-14
Methods Of Treating Apol-1 Dependent Focal Segmental Glomerulosclerosis
App 20210275496 - Mallalieu; Navita ;   et al.
2021-09-09
Method for treating cancer using a combination of DNA-damaging agents and DNA-PK inhibitors
Grant 11,110,108 - Boucher , et al. September 7, 2
2021-09-07
Compounds useful as inhibitors of ATR kinase and combination therapies thereof
Grant 11,110,086 - Pollard , et al. September 7, 2
2021-09-07
Methods Of Treatment For Alpha-1 Antitrypsin Deficiency
App 20210260036 - BOZIC; Carmen ;   et al.
2021-08-26
Solid Forms Of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline- -3-carboxamide
App 20210251978 - Hurter; Patricia ;   et al.
2021-08-19
Solid Forms Of Apol1 Inhibitor And Methods Of Using Same
App 20210246121 - LAI; Mei-Hsiu ;   et al.
2021-08-12
Processes For Making Modulators Of Cystic Fibrosis Transmembrane Conductance Regulator
App 20210246117 - Angell; Paul T. ;   et al.
2021-08-12
Modulators of ATP-binding cassette transporters
Grant 11,084,804 - Hadida Ruah , et al. August 10, 2
2021-08-10
Process Of Producing Cycloalkylcarboxamido-indole Compounds
App 20210238158 - Tanoury; Gerald J. ;   et al.
2021-08-05
Substituted Quinoxaline Dna-pk Inhibitors
App 20210236505 - Maxwell; John Patrick ;   et al.
2021-08-05
Stem Cell Derived Islet Differentiation
App 20210238553 - Pagliuca; Felicia J. ;   et al.
2021-08-05
Compositions For Treating Cystic Fibrosis
App 20210228489 - Dokou; Eleni ;   et al.
2021-07-29
Modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulators
Grant 11,066,417 - Clemens , et al. July 20, 2
2021-07-20
Pteridinone compounds and uses thereof
Grant 11,059,826 - Lauffer , et al. July 13, 2
2021-07-13
Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid and administration thereof
Grant 11,052,075 - Verwijs , et al. July 6, 2
2021-07-06
Methods Of Enhancing Stem Cell Differentiation Into Beta Cells
App 20210198632 - Pagliuca; Felicia ;   et al.
2021-07-01
Substituted Tetrahydrofurans As Modulators Of Sodium Channels
App 20210198241 - Durrant; Steven John
2021-07-01
Methods Of Cancer Treatment Using An Atr Inhibitor
App 20210196751 - PENNEY; Marina S. ;   et al.
2021-07-01
Materials And Methods For Treatment Of Hemoglobinopathies
App 20210180091 - Chakraborty; Tirtha ;   et al.
2021-06-17
Modulators Of Alpha-1 Antitrypsin
App 20210179587 - BANDARAGE; Upul Keerthi ;   et al.
2021-06-17
DNA-PK inhibitors
Grant 11,021,465 - Charifson , et al. June 1, 2
2021-06-01
Deuterated Pyridone Amides And Prodrugs Thereof As Modulators Of Sodium Channels
App 20210155643 - JIANG; Licong ;   et al.
2021-05-27
DNA-PK inhibitors
Grant 11,008,305 - Charifson , et al. May 18, 2
2021-05-18
Modulators Of Cystic Fibrosis Transmembrane Conductance Regulator
App 20210139514 - ABELA; Alexander Russell ;   et al.
2021-05-13
GCN2 inhibitors and uses thereof
Grant 10,988,477 - Bayly , et al. April 27, 2
2021-04-27
Modulators of ATP-binding cassette transporters
Grant 10,987,348 - Hadida Ruah , et al. April 27, 2
2021-04-27
Methods Of Treatment For Cystic Fibrosis
App 20210113547 - Chen; Weichao George ;   et al.
2021-04-22
Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases
Grant 10,980,746 - Phenix , et al. April 20, 2
2021-04-20
Substituted quinoxaline DNA-PK inhibitors
Grant 10,973,830 - Maxwell , et al. April 13, 2
2021-04-13
Modulators of ATP-binding cassette transporters
Grant 10,975,061 - Hadida Ruah , et al. April 13, 2
2021-04-13
Carboxamides As Modulators Of Sodium Channels
App 20210094906 - Ahmad; Nadia M. ;   et al.
2021-04-01
Substituted pyrazines as ATR kinase inhibitors
Grant 10,961,232 - Charrier , et al. March 30, 2
2021-03-30
Compositions And Methods For Treatment Of Cystic Fibrosis
App 20210069174 - Chu; Cathy ;   et al.
2021-03-11
Dna-pk Inhibitors
App 20210069203 - Maxwell; John Patrick ;   et al.
2021-03-11
Dna-pk Inhibitors
App 20210060028 - WEINBERG; Marc Saul ;   et al.
2021-03-04
A Method Of Treating Pain
App 20210052610 - AGARWAL; Sagar ;   et al.
2021-02-25
Modulators Of Cystic Fibrosis Transmembrane Conductance Regulator
App 20210052584 - Miller; Mark Thomas ;   et al.
2021-02-25
Process Of Making Cftr Modulators
App 20210047345 - Angell; Paul ;   et al.
2021-02-18
Crispr/cas All-in-two Vector Systems For Treatment Of Dmd
App 20210047649 - NG; Robert ;   et al.
2021-02-18
Pyridone Amides As Modulators Of Sodium Channels
App 20210047271 - Hadida Ruah; Sara Sabina ;   et al.
2021-02-18
Modulator Of The Cystic Fibrosis Transmembrane Conductance Regulator, Pharmaceutical Compositions, Methods Of Treatment, And Process For Making The Modulator
App 20210047295 - Abela; Alexander Russell ;   et al.
2021-02-18
Compounds Useful As Inhibitors Of Atr Kinase
App 20210047333 - AHMAD; Nadia ;   et al.
2021-02-18
Crystalline Forms Of Cftr Modulators
App 20210047323 - Shi; Yi ;   et al.
2021-02-18
Modulators Of Cystic Fibrosis Transmembrane Conductance Regulator
App 20210047350 - Anderson; Corey Don ;   et al.
2021-02-18
Gcn2 Inhibitors And Uses Thereof
App 20210040083 - Bleich; Matthew ;   et al.
2021-02-11
2,7-dibromospiro[fluorene-9,4'-piperidine] compounds
Grant 10,913,761 - Ramtohul , et al. February 9, 2
2021-02-09
Modulators Of Cystic Fibrosis Transmembrane Conductance Regulator, Pharmaceutical Compositions, Methods Of Treatment, And Process For Making The Modulator
App 20210032272 - ABELA; Alexander Russell ;   et al.
2021-02-04
Compounds Useful As Inhibitors Of Atr Kinase
App 20210032255 - CHARRIER; Jean-Damien ;   et al.
2021-02-04
Solid forms of (R)-1(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-- fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxa- mide
Grant 10,906,891 - Keshavarz-Shokri , et al. February 2, 2
2021-02-02
Pharmaceutical Composition And Administrations Thereof
App 20210023070 - Rowe; William ;   et al.
2021-01-28
Modulators Of Atp-binding Cassette Transporters
App 20210024505 - HADIDA RUAH; Sara S. ;   et al.
2021-01-28
Implantation Devices, System, And Methods
App 20210016073 - Thanos; Christopher ;   et al.
2021-01-21
Formulations Of Azaindole Compounds
App 20210008072 - Simone; Eric Arthur ;   et al.
2021-01-14
Materials And Methods For Treatment Of Hemoglobinopathies
App 20210009998 - Porteus; Matthew Hebden
2021-01-14
Crystalline Forms Of Modulators Of Cftr
App 20210009560 - LEE; Elaine Chungmin ;   et al.
2021-01-14
Inhibitors of influenza viruses replication
Grant 10,875,855 - Charifson , et al. December 29, 2
2020-12-29
Inhibitors of influenza viruses replication
Grant 10,874,673 - Charifson , et al. December 29, 2
2020-12-29
Treating Cancer With Atr Inhibitors
App 20200390761 - POLLARD; John Robert ;   et al.
2020-12-17
Crystalline Forms And Compositions Of Cftr Modulators
App 20200392109 - Dhamankar; Varsha ;   et al.
2020-12-17
Crispr-cas9 Modified Cd34+ Human Hematopoietic Stem And Progenitor Cells And Uses Thereof
App 20200384033 - Morawa; Ewelina ;   et al.
2020-12-10
Inhibitors Of Apol1 And Methods Of Using Same
App 20200377479 - CAO; Jingrong ;   et al.
2020-12-03
Solid Forms Of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-- Methylpyridin-2-yl) Benzoic Acid
App 20200377484 - Keshavarz-Shokri; Ali ;   et al.
2020-12-03
Prodrugs Of Pyridone Amides Useful As Modulators Of Sodium Channels
App 20200377535 - Anderson; Corey ;   et al.
2020-12-03
Processes For Preparing Pyrrolidine Compounds
App 20200369608 - Angell; Paul T. ;   et al.
2020-11-26
Modulators Of Alpha-1 Antitrypsin
App 20200361939 - BANDARAGE; Upul Keerthi ;   et al.
2020-11-19
Quinoxalinone Compounds, Compositions, Methods, And Kits For Increasing Genome Editing Efficiency
App 20200361877 - MAHAJAN; Sudipta ;   et al.
2020-11-19
Solid Forms Of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline- -3-carboxamide
App 20200352930 - Hurter; Patricia ;   et al.
2020-11-12
Dna-pk Inhibitors
App 20200353101 - MAXWELL; John Patrick ;   et al.
2020-11-12
Processes for preparing ATR inhibitors
Grant 10,822,331 - Charrier , et al. November 3, 2
2020-11-03
Pharmaceutical Compositions For The Treatment Of Cftr Mediated Diseases
App 20200338063 - VERWIJS; Marinus Jacobus ;   et al.
2020-10-29
CRYSTALLINE FORMS OF C21H22Cl2N4O2
App 20200339531 - DeCrescenzo; Gary ;   et al.
2020-10-29
Antiproliferation compounds and uses thereof
Grant 10,815,225 - Yu , et al. October 27, 2
2020-10-27
Compounds useful as inhibitors of ATR kinase
Grant 10,815,239 - Charrier , et al. October 27, 2
2020-10-27
Treating cancer with ATR inhibitors
Grant 10,813,929 - Pollard , et al. October 27, 2
2020-10-27
Pyrrole inhibitors of ERK protein kinase, synthesis thereof and intermediates thereto
Grant RE48,266 - Botella , et al. October 20, 2
2020-10-20
Compounds useful as inhibitors of ATR kinase
Grant 10,800,781 - Ahmad , et al. October 13, 2
2020-10-13
Influenza A virus variants
Grant 10,801,077 - Leeman , et al. October 13, 2
2020-10-13
Influenza A virus variants
Grant 10,801,076 - Leeman , et al. October 13, 2
2020-10-13
GCN2 inhibitors and uses thereof
Grant 10,793,563 - Bleich , et al. October 6, 2
2020-10-06
Modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
Grant 10,793,547 - Abela , et al. October 6, 2
2020-10-06
DNA-PK inhibitors
Grant 10,786,512 - Maxwell , et al. September 29, 2
2020-09-29
Compounds useful as inhibitors of ATR kinase
Grant 10,787,452 - Ahmad , et al. September 29, 2
2020-09-29
Prodrugs of pyridone amides useful as modulators of sodium channels
Grant 10,787,472 - Anderson , et al. September 29, 2
2020-09-29
Processes For Making Modulators Of Cystic Fibrosis Transmembrane Conductance Regulator
App 20200290972 - Lemercier Lewandowski; Berenice ;   et al.
2020-09-17
Modulator Of Cystic Fibrosis Transmembrane Conductance Regulator, Pharmaceutical Compositions, Methods Of Treatment, And Process
App 20200283405 - Alcacio; Timothy ;   et al.
2020-09-10
Triazoles for the treatment of demyelinating dieases
Grant 10,766,869 - Davies , et al. Sep
2020-09-08
Modulators of cystic fibrosis transmembrane conductance regulator
Grant 10,758,534 - Miller , et al. Sep
2020-09-01
Mannose Derivatives for Treating Bacterial Infections
App 20200270293 - Ramtohul; Yeeman K. ;   et al.
2020-08-27
Pyridone amides as modulators of sodium channels
Grant 10,738,009 - Hadida Ruah , et al. A
2020-08-11
Materials and methods for treatment of hemoglobinopathies
Grant 10,738,305 - Porteus A
2020-08-11
Modulators of cystic fibrosis transmembrane conductance regulator
Grant 10,738,030 - Bear , et al. A
2020-08-11
Crystalline forms of C.sub.21H.sub.22Cl.sub.2N.sub.4O.sub.2
Grant 10,738,027 - DeCrescenzo , et al. A
2020-08-11
Co-crystals and pharmaceutical compositions comprising the same
Grant 10,716,789 - Nti-Addae , et al.
2020-07-21
Compounds Useful As Inhibitors Of Atr Kinase And Combination Therapies Thereof
App 20200222392 - Pollard; John Robert ;   et al.
2020-07-16
Methods Of Preparing Inhibitors Of Influenza Viruses Replication
App 20200207765 - Tanoury; Gerald J. ;   et al.
2020-07-02
Pharmaceutical Compositions Of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) Cyclopropanecarboxamido)-3-methylpyridin-2-yl) Ben
App 20200197380 - Verwijs; Marinus Jacobus ;   et al.
2020-06-25
Methods Of Treatment For Cystic Fibrosis
App 20200171015 - Haseltine; Eric L. ;   et al.
2020-06-04
Mannose derivatives for treating bacterial infections
Grant 10,669,298 - Ramtohul , et al.
2020-06-02
Modulators of ATP-binding cassette transporters
Grant 10,662,192 - Hadida-Ruah , et al.
2020-05-26
Crystalline forms and compositions of CFTR modulators
Grant 10,654,829 - Dhamankar , et al.
2020-05-19
Pharmaceutical composition and administrations thereof
Grant 10,646,481 - Rowe , et al.
2020-05-12
Carboxamides as modulators of sodium channels
Grant 10,647,661 - Ahmad , et al.
2020-05-12
Methods Of Treatment For Cystic Fibrosis
App 20200138798 - Chen; Weichao George ;   et al.
2020-05-07
Compounds Useful As Inhibitors Of Atr Kinase
App 20200140441 - Ahmad; Nadia ;   et al.
2020-05-07
Methods of preparing inhibitors of influenza viruses replication
Grant 10,640,501 - Tanoury , et al.
2020-05-05
Modulators of ATP-binding cassette transporters
Grant 10,626,111 - Hadida Ruah , et al.
2020-04-21
Modulators Of Atp-binding Cassette Transporters
App 20200115366 - HADIDA RUAH; Sara S. ;   et al.
2020-04-16
Dna-pk Inhibitors
App 20200109130 - Charifson; Paul S. ;   et al.
2020-04-09
Solid forms of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-- methylpyridin-2-yl) benzoic acid
Grant 10,597,384 - Keshavarz-Shokri , et al.
2020-03-24
Formulations Of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) Cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic Acid
App 20200085750 - Verwijs; Marinus Jacobus
2020-03-19
Dna-pk Inhibitors
App 20200062732 - Charifson; Paul S. ;   et al.
2020-02-27
Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
Grant 10,570,115 - Alcacio , et al. Feb
2020-02-25
Combination Therapies For Treating Influenza Virus Infection
App 20200054633 - Kauffman; Robert S. ;   et al.
2020-02-20
Prodrug Of An Ice Inhibitor
App 20200048306 - WANNAMAKER; Marion W. ;   et al.
2020-02-13
Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline- -3-carboxamide
Grant 10,537,565 - Hurter , et al. Ja
2020-01-21
Method For Treating Cancer Using A Combination Of Dna-damaging Agents And Dna-pk Inhibitors
App 20200016181 - Boucher; Diane M. ;   et al.
2020-01-16
Methods of preparing inhibitors of influenza viruses replication
Grant 10,533,004 - Farmer , et al. Ja
2020-01-14
DNA-PK inhibitors
Grant 10,501,439 - Charifson , et al. Dec
2019-12-10
Compounds useful as inhibitors of ATR kinase and combination therapies thereof
Grant 10,478,430 - Pollard , et al. Nov
2019-11-19
Substituted pyrazin-2-amines as inhibitors of ATR kinase
Grant 10,479,784 - Charrier , et al. Nov
2019-11-19
Method Of Treating Pain
App 20190343817 - Agarwal; Sagar ;   et al.
2019-11-14
Modulators Of Atp-binding Cassette Transporters
App 20190322650 - HADIDA RUAH; Sara S. ;   et al.
2019-10-24
Antiproliferation Compounds And Uses Thereof
App 20190322658 - Yu; Henry ;   et al.
2019-10-24
Pteridinone Compounds And Uses Thereof
App 20190322673 - Lauffer; David J. ;   et al.
2019-10-24
DNA-PK inhibitors
Grant 10,442,791 - Charifson , et al. Oc
2019-10-15
Processes for preparing ATR inhibitors
Grant 10435397 -
2019-10-08
Dna-pk Inhibitors
App 20190290654 - Maxwell; John Patrick ;   et al.
2019-09-26
Pharmaceutical Composition And Administrations Thereof
App 20190274959 - DOKOU; Eleni ;   et al.
2019-09-12
Prodrugs Of Pyridone Amides Useful As Modulators Of Sodium Channels
App 20190276483 - Anderson; Corey ;   et al.
2019-09-12
Mannose derivatives for treating bacterial infections
Grant 10,407,414 - Gallant , et al. Sept
2019-09-10
Modulators Of Cystic Fibrosis Transmembrane Conductance Regulator
App 20190269683 - Miller; Mark Thomas ;   et al.
2019-09-05
Solid Forms of (R)-1(2,2-Difluorobenzo[D][1,3]Dioxol-5-yl)-N-(1-(2,3-Dihydroxypropyl)-6-- Fluoro-2-(1-Hydroxy-2-Methylpropan-2-y
App 20190270728 - Keshavarz-Shokri; Ali ;   et al.
2019-09-05
Compounds useful as inhibitors of ATR kinase
Grant 10,392,391 - Ahmad , et al. A
2019-08-27
DNA-PK inhibitors
Grant 10,391,095 - Charifson , et al. August 27, 2
2019-08-27
Dna-pk Inhibitors
App 20190255062 - Maxwell; John Patrick ;   et al.
2019-08-22
Compounds Useful As Inhibitors Of Atr Kinase
App 20190256516 - Charrier; Jean-Damien ;   et al.
2019-08-22
Chroman-spirocyclic piperidine amides as modulators of ion channels
Grant 10,385,070 - Hadida-Ruah , et al. A
2019-08-20
Pyridone Amides As Modulators Of Sodium Channels
App 20190248745 - Hadida Ruah; Sara Sabina ;   et al.
2019-08-15
Modulators of Cystic Fibrosis Transmembrane Conductance Regulator, Pharmaceutical Compositions, Methods of Treatment, and Proces
App 20190248809 - Clemens; Jeremy J. ;   et al.
2019-08-15
Pharmaceutical Compositions For Treating Cystic Fibrosis
App 20190240197 - Chu; Cathy ;   et al.
2019-08-08
Gcn2 Inhibitors And Uses Thereof
App 20190233411 - Bleich; Matthew ;   et al.
2019-08-01
Gcn2 Inhibitors And Uses Thereof
App 20190233425 - Bayly; Andrew ;   et al.
2019-08-01
Methods, Compositions And Kits For Increasing Genome Editing Efficiency
App 20190225990 - Abdul-Manan; Norzehan ;   et al.
2019-07-25
Process Of Producing Cycloalkylcarboxamido-indole Compounds
App 20190210991 - Tanoury; Gerald J. ;   et al.
2019-07-11
Processes For Preparing Atr Inhibitors
App 20190202818 - Charrier; Jean-Damien ;   et al.
2019-07-04
Triazoles For The Treatment Of Demyelinating Diseases
App 20190185436 - Davies; Robert J. ;   et al.
2019-06-20
Process For The Preparation Of A 1,3-disubstituted Pyrazole Compound
App 20190177295 - Bligh; Cavan McKeon ;   et al.
2019-06-13
Process of conducting high throughput testing high performance liquid chromatography
Grant 10,302,602 - Borsje , et al.
2019-05-28
Selective inhibitor of phosphatidylinositol 3-kinase-gamma
Grant 10,301,304 - Boyd , et al.
2019-05-28
Inhibitors Of Influenza Viruses Replication
App 20190151314 - Charifson; Paul S. ;   et al.
2019-05-23
Modulators Of Atp-binding Cassette Transporters
App 20190144450 - Hadida-Ruah; Sara ;   et al.
2019-05-16
Pharmaceutical Compositions For The Treatment Of Cystic Fibrosis Transmembrane Conductance Regulator Mediated Diseases
App 20190125674 - Phenix; Brian Dean ;   et al.
2019-05-02
CRYSTALLINE FORMS OF C21H22Cl2N4O2
App 20190127348 - DeCrescenzo; Gary ;   et al.
2019-05-02
Pharmaceutical composition and administrations thereof
Grant 10,272,046 - Dokou , et al.
2019-04-30
Inhibitors of influenza viruses replication
Grant 10,273,233 - Farmer , et al.
2019-04-30
Imidazopyridazines Useful As Inhibitors Of The Par-2 Signaling Pathway
App 20190119282 - Farmer; Luc J. ;   et al.
2019-04-25
Crystalline Forms And Compositions Of Cftr Modulators
App 20190119253 - Dhamankar; Varsha ;   et al.
2019-04-25
DNA-PK inhibitors
Grant 10,258,627 - Maxwell , et al.
2019-04-16
Modulators of cystic fibrosis transmembrane conductance regulator
Grant 10,258,624 - Miller , et al.
2019-04-16
Mannose Derivatives for Treating Bacterial Infections
App 20190106450 - Ramtohul; Yeeman K. ;   et al.
2019-04-11
Prodrugs of pyridone amides useful as modulators of sodium channels
Grant 10,253,054 - Anderson , et al.
2019-04-09
Pyrrole inhibitors of erk protein kinase, synthesis thereof and intermediates thereto
Grant RE47,318 - Botella , et al.
2019-03-26
Modulators of ATP-binding cassette transporters
Grant 10,239,867 - Hadida Ruah , et al.
2019-03-26
Fused piperidine amides as modulators of ion channels
Grant 10,233,191 - Deninno , et al.
2019-03-19
Process of preparing pharmaceutical compositions for the treatment of CFTR mediated diseases
Grant 10,231,932 - Swinney , et al.
2019-03-19
Modulators Of Atp-binding Cassette Transporters
App 20190076419 - HADIDA RUAH; Sara Sabina ;   et al.
2019-03-14
Solid Forms Of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline- -3-carboxamide
App 20190070162 - Hurter; Patricia ;   et al.
2019-03-07
Pharmaceutical Compositions Of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) Cyclopropanecarboxamido)-3-methylpyridin-2-yl) Benzoic Acid And Administration Thereof
App 20190070155 - VERWIJS; Marinus Jacobus ;   et al.
2019-03-07
Modulators Of Cystic Fibrosis Transmembrane Conductance Regulator
App 20190055220 - Bear; Brian ;   et al.
2019-02-21
Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases
Grant 10,206,877 - Phenix , et al. Feb
2019-02-19
Processes for preparing ATR inhibitors
Grant 10,208,027 - Charrier , et al. Feb
2019-02-19
Compounds Useful As Inhibitors Of Atr Kinase
App 20190047995 - CHARRIER; Jean-Damien ;   et al.
2019-02-14
Pharmaceutical Compositions And Administrations Thereof
App 20190038615 - Van Goor; Fredrick F. ;   et al.
2019-02-07
Crystalline forms of C.sub.21H.sub.22Cl.sub.2N.sub.4O.sub.2
Grant 10,183,927 - DeCrescenzo , et al. Ja
2019-01-22
Isoindolinone inhibitors of phosphatidylinositol 3-kinase
Grant 10,183,933 - Aronov , et al. Ja
2019-01-22
Carboxamides As Modulators Of Sodium Channels
App 20190016671 - AHMAD; Nadia ;   et al.
2019-01-17
Compounds Useful As Inhibitors Of Atr Kinase
App 20190010163 - Ahmad; Nadia ;   et al.
2019-01-10
Compounds useful as inhibitors of ATR kinase
Grant 10,160,760 - Charrier , et al. Dec
2018-12-25
Prodrug Of An Ice Inhibitor
App 20180327449 - WANNAMAKER; Marion W. ;   et al.
2018-11-15
Triazoles for the treatment of Demyelinating Diseases
Grant 10,118,904 - Davies , et al. November 6, 2
2018-11-06
Compounds useful as inhibitors of ATR kinase
Grant 10,093,676 - Ahmad , et al. October 9, 2
2018-10-09
Pyridone amides as modulators of sodium channels
Grant 10,087,143 - Hadida-Ruah , et al. October 2, 2
2018-10-02
Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-- fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxa- mide
Grant 10,081,621 - Keshavarz-Shokri , et al. September 25, 2
2018-09-25
Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid and administration thereof
Grant 10,076,513 - Verwijs , et al. September 18, 2
2018-09-18
DNA-PK inhibitors
Grant 10,076,521 - Charifson , et al. September 18, 2
2018-09-18
Process of producing cycloalkylcarboxamido-indole compounds
Grant 10,071,979 - Tanoury , et al. September 11, 2
2018-09-11
Pharmaceutical compositions of (R)-1-(2,2-difluorobenzo[D][1,3]dioxo1-5-y1)-N-(1-(2,3-dihydroxypropy1)-6- -fluoro-2-(1-hydroxy-2-methylpropan-2-y1)-1H-indol-5-y1) cyclopropanecarbox-amide and administration thereof
Grant 10,058,546 - Alargova , et al. August 28, 2
2018-08-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed